Developmental Research Program
Developmental Research Program
批准号:
10468833
负责人:
MARK A. MC NIVEN
金额:
$5.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-10 至 2024-08-31
关键词:
Advisory CommitteesAwardClinicClinicalClinical ResearchDataDevelopmentDisabled PersonsEnsureEvaluationFundingFutureGenerationsGoalsHepatobiliaryLaboratoriesLeadershipMinority WomenMonitorMorbidity - disease ratePatientsPeer ReviewPopulationPopulation SciencesProcessProgram Research Project GrantsResearchResearch PersonnelResearch Project GrantsResourcesSecureTranslatingTranslational ResearchWorkanticancer researchbaseexperiencehepatobiliary cancerhigh riskinnovationmortalityoriginalityprogramsrecruittranslational potential
中文摘要
实验研究-项目总结
马约诊所HBCs SPORE发展研究计划(DRP)的目标是吸引,发展,
支持和监测与转化性肝胆癌有关的最有前途和创新的项目
research. DRP每年将提供三个为期一年的奖励,每个奖励5万美元,并有可能获得
根据所展示的重大进展和潜力,再提供一年的支助。一个严格的同行-
利用内部科学咨询委员会和其他有经验的专家的专门知识,
研究人员将根据以下标准评估所有申请:科学价值,原创性,
申请人/合作研究者的资质和翻译潜力。虽然平移轨迹
所有的应用程序都需要显而易见,我们鼓励高风险/高回报的建议,调查所有
关于肝胆癌发病率和死亡率的方面,从实验室到人群。这
将通过以下具体目标来实现:(1)征求和支持创新和
肝胆疾病的跨学科预防相关实验室、人口科学和临床研究
癌症;(2)鼓励招募合格的少数族裔、妇女和残疾人;(3)提供
对所有DRP申请和获奖者的进展进行严格评估;以及(4)促进DRP的发展
R 01级应用程序和/或未来的HBCs SPORE项目。预计在
发展研究项目的支持将产生数据,作为基础,
额外的负担沉重国家通过其他外部同行审查机制赞助项目或提供支助。
HBCs SPORE领导层将与调查人员合作,帮助获得独立的R 01级资金。
三个潜在的研究项目的一页大纲包括展示的深度和广度
正在进行的研究,可以通过HBCs SPORE发展研究获得资助
程序.
英文摘要
DEVELOPMENTAL RESEARCH PROGRAM – PROJECT SUMMARY
The goal of the Mayo Clinic HBCs SPORE Developmental Research Program (DRP) is to attract, develop,
support, and monitor the most promising and innovative projects pertaining to translational hepatobiliary cancer
research. Each year the DRP will provide three, one-year awards of $50,000 each with the possibility of an
additional year of support based upon the demonstration of significant progress and potential. A rigorous peer-
review process utilizing the expertise of the Internal Scientific Advisory Committee and other experienced
investigators will evaluate all applications based upon the following criteria: scientific merit, originality,
qualifications of the applicant/co-investigator(s), and translational potential. While the translational trajectory of
all applications needs to be readily apparent, we encourage high risk/high payoff proposals investigating all
aspects pertaining to the morbidity and mortality of hepatobiliary cancer from the bench to the population. This
will be accomplished through the following Specific Aims: (1) Solicit and support innovative and
interdisciplinary translationally-relevant laboratory, population science, and clinical studies in hepatobiliary
cancer; (2) Encourage the recruitment of qualified minorities, women, and persons with disabilities; (3) Provide
critical evaluation of all DRP applications and awardee progress; and (4) Facilitate the development of DRP
funded proposals into R01-level applications and/or future HBCs SPORE projects. It is expected that
developmental research project support will result in the generation of data that will serve as the basis for
additional HBCs SPORE-sponsored projects or support through other external peer-reviewed mechanisms.
The HBCs SPORE leadership will work with the investigators to help secure independent R01-level funding.
One-page outlines of three potential research projects are included to demonstrate the depth and breadth of
ongoing research that can be eligible for funding through the HBCs SPORE Developmental Research
Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of a mitochondria-associated metastasis regulatory mechanism
-
批准号:10693170
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2021
-
负责人:MARK A. MC NIVEN
-
依托单位:
Fast super-resolution/confocal microscopy for GI cell biology
-
批准号:10173129
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2021
-
负责人:MARK A. MC NIVEN
-
依托单位:
Investigation of a mitochondria-associated metastasis regulatory mechanism
-
批准号:10209266
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2021
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10493808
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10707676
-
项目类别:
-
资助金额:$13.76万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10468826
-
项目类别:
-
资助金额:$35.71万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10411346
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10006076
-
项目类别:
-
资助金额:$30.13万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10005922
-
项目类别:
-
资助金额:$229.42万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10527395
-
项目类别:
-
资助金额:$13.76万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10493805
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Core A: Administrative Core
-
批准号:10251129
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10251127
-
项目类别:
-
资助金额:$194.07万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE
-
批准号:10468825
-
项目类别:
-
资助金额:$211.69万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Mayo Clinic Hepatobiliary SPORE Diversity Supplement Dr. Musa Gabere
-
批准号:10310895
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Developmental Research Program
-
批准号:10251137
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2018
-
负责人:MARK A. MC NIVEN
-
依托单位:
Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer
-
批准号:8186136
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2011
-
负责人:MARK A. MC NIVEN
-
依托单位:
Novel therapeutic inhibition of the Rac oncogene in pancreatic cancer
-
批准号:8298132
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2011
-
负责人:MARK A. MC NIVEN
-
依托单位:
Tumor Microenvironment/Angiogenesis Training Grant
-
批准号:8680175
-
项目类别:
-
资助金额:$25.36万
-
财政年份:2010
-
负责人:MARK A. MC NIVEN
-
依托单位:
Optical Microscopy Core
-
批准号:7760767
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2009
-
负责人:MARK A. MC NIVEN
-
依托单位:
海外基金